Press release
Cell Therapy Market to Surpass US$ 54.6 Bn by 2032, Latest Study by TMR
Cell Therapy
๐๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ :
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=63273&utm_source=OpenPR&utm_campaign=MansiR_OpenPR
๐๐ก๐๐ญ ๐ ๐๐๐ญ๐จ๐ซ๐ฌ ๐๐ซ๐ ๐๐ซ๐จ๐ฉ๐๐ฅ๐ฅ๐ข๐ง๐ ๐๐๐ฅ๐ฅ ๐๐ก๐๐ซ๐๐ฉ๐ฒ ๐๐๐ฆ๐๐ง๐?
Cell and gene therapies (CGTs) represent cutting-edge technology for treating severe and rare diseases.
LUXTURNA, a therapy targeting a hereditary retinal illness causing blindness, is among several such treatments available.
CGT signifies a significant medical advancement, notably as the first curative gene therapy approved for use.
In August 2020, the FDA approved Novartis' Kymriah for refractory follicular lymphoma, marking a milestone in regenerative medicine.
July 2020 saw FDA approval for brexucabtagene Acelus, a CAR T-cell therapy for mantle cell lymphoma patients.
Ongoing development efforts are evident, with over 750 CGT studies involving around 30,000 patients as of June 2020.
CGT drugs comprise approximately 12% of the pharmaceutical industry's clinical pipeline and at least 16% of the preclinical pipeline.
The demand for novel therapies, such as cancer and cardiovascular treatments, is driving research into cell-based solutions.
The Australian government launched the Cell Therapies Mission in November 2019, allocating US$ 102 million under the Medical Research Future Fund (MRFF) to incentivize stem cell research for new medicines.
Foster Innovation UK received GBP 267,000 in funding in September 2019 to support gel stabilization technology developed by Atelerix, with a focus on therapeutic applications.
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ:
Novartis AG, Pharmicell, Osiris Therapeutics (Smith & Nephew), GlaxoSmithKline, Anterogen, IMFS, Stemedica Cell Technologies, NuVasive, BioNTech, Kolon TissueGene, JCR Pharmaceuticals, Cells for Cells, and Vericel Corporation.
๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐ฌ:
By Use Type
Clinical use
Therapeutic Area
Cell Type
Research Use
Byย Therapy Type
Allogenic Therapies
Autologous Therapies
By Region
North America
Latin America
Europe
APAC
MEA
๐๐๐๐๐ง๐ญ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ๐ฌ:
In April 2019, Hitachi Chemical Co. Ltd. bought apceth Biopharma GmbH to expand its foothold in the contract development and manufacturing organization (CDMO) industry for gene and cell therapies production.
In June 2021, Charles River Laboratories acquired a cellular and gene therapy contract manufacturer-to-manufacturing capabilities through the acquisition of CDMO Cognate BioServices.
In August 2021,ย Thermo Fisher Scientific paid US$ 859.7 million for Henogen S.A., Novasep's viral vector production firm in Belgium. This purchase strengthens its position in the cell and gene therapy manufacturing therapeutic sector.
In July 2019,ย Thermo Fisher Scientific paid US$ 1.7 billion for Brammer Bio, a business that manufactures viral vectors for gene and cell treatments.
๐๐ซ๐๐๐ซ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.transparencymarketresearch.com/checkout.php?rep_id=63273<ype=S&utm_source=OpenPR&utm_campaign=MansiR_OpenPR
๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐ง๐๐ฌ:
Emergence of personalized cell therapies
Integration of artificial intelligence and machine learning in cell therapy development
Shift towards off-the-shelf cell therapies
Collaborations and partnerships among pharmaceutical companies and research institutes
๐ ๐ฎ๐ญ๐ฎ๐ซ๐ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค:
The future of the cell therapy market appears promising, with continuous innovation and technological advancements driving the development of safer and more effective therapies. As research uncovers new applications and expands the understanding of cellular mechanisms, the landscape of healthcare is set to undergo transformative changes.
๐๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐ญ๐ฎ๐๐ฒ ๐๐จ๐ข๐ง๐ญ๐ฌ:
Understanding patient demographics and disease prevalence
Assessing regulatory landscapes across different regions
Analyzing competitive strategies and market positioning of key players
Monitoring advancements in cell manufacturing and therapy delivery techniques
Identifying emerging opportunities in niche therapeutic areas
๐๐ซ๐จ๐ฐ๐ฌ๐ ๐๐จ๐ซ๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ฒ ๐๐๐:
๐๐๐ฎ๐ญ๐ ๐๐ฒ๐๐ฅ๐จ๐ข๐ ๐๐๐ฎ๐ค๐๐ฆ๐ข๐ (๐๐๐) ๐๐ข๐จ๐ฆ๐๐ซ๐ค๐๐ซ ๐๐๐ฌ๐ญ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ- https://www.globenewswire.com/news-release/2023/03/15/2627542/0/en/Acute-Myeloid-Leukemia-AML-Biomarker-Testing-Market-to-Hit-USD-624-0-Mn-by-2031-Says-Transparency-Market-Research.html
๐๐ฎ๐ญ๐จ๐ฆ๐จ๐ญ๐ข๐ฏ๐ ๐๐๐๐ญ๐ก๐๐ซ ๐๐ฉ๐ก๐จ๐ฅ๐ฌ๐ญ๐๐ซ๐ฒ ๐๐๐ซ๐ค๐๐ญ- https://www.globenewswire.com/news-release/2023/03/15/2627439/0/en/Automotive-Leather-Upholstery-Market-to-Reach-US-7-0-Bn-by-2031-Europe-is-expected-to-dominate-the-worldwide-market-Transparency-Market-Research-Inc.html
๐๐๐จ๐ฎ๐ญ ๐๐ซ๐๐ง๐ฌ๐ฉ๐๐ซ๐๐ง๐๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก
Transparency Market Research, a globalย market research companyย registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
๐๐จ๐ง๐ญ๐๐๐ญ:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.comย ย ย
Email:ย sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cell Therapy Market to Surpass US$ 54.6 Bn by 2032, Latest Study by TMR here
News-ID: 3424160 • Views: โฆ
More Releases from Transparency Market Research
Global Coal Market Outlook 2036: Industry to Reach US$ 2,558.8 Billion by 2036 D โฆ
The global coal market was valued at US$ 1,595.1 Bn in 2025 and is projected to reach US$ 2,558.8 Bn by 2036, expanding at a CAGR of 4.4% from 2026 to 2036. The industry continues to remain a cornerstone of global energy systems, particularly in emerging economies where coal-fired power generation supports industrialization and infrastructure growth.
Asia Pacific dominated the global coal market in 2025, accounting for 83.0% of total revenueโฆ
Metalworking Fluids Market Expanding at 3.7% CAGR Through 2036 - By Type / By Ap โฆ
The global metalworking fluids market was valued at US$ 11.8 Bn in 2025 and is projected to reach US$ 17.6 Bn by 2036, expanding at a steady CAGR of 3.7% during the forecast period from 2026 to 2036. The market's moderate yet stable growth trajectory reflects its strong integration into essential industrial operations across automotive, aerospace, construction, marine, medical, and heavy engineering sectors.
Get a concise overview of key insights fromโฆ
Bio-based Epoxy Resin Market to Reach US$ 11.5 Billion by 2036 Amid Sustainabili โฆ
The global bio-based epoxy resin market is entering a transformative growth phase as industries shift toward sustainable and low-carbon material solutions. Valued at US$ 6.4 billion in 2025, the market is projected to reach US$ 11.5 billion by 2036, expanding at a CAGR of 5.5% from 2026 to 2036. Increasing regulatory pressure, evolving sustainability mandates, and the growing adoption of renewable raw materials are accelerating demand across multiple end-use industries.
Bio-basedโฆ
Plant Growth Regulators Market to Reach US$ 11.97 Billion by 2036, Driven by Ris โฆ
The global plant growth regulators market was valued at US$ 7,569.9 Mn in 2025 and is projected to reach US$ 11,971.1 Mn by 2036, expanding at a compound annual growth rate (CAGR) of 4.2% from 2026 to 2036. Market growth is primarily driven by rising pressure to improve agricultural productivity and the rapid expansion of high-value crops and protected cultivation systems worldwide.
Access key findings and insights from our Report inโฆ
More Releases for Cell
Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R โฆ
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting.
Download Full PDF Sample Copyโฆ
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re โฆ
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnologicalโฆ
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod โฆ
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Currentโฆ
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp โฆ
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,โฆ
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect โฆ
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, typeโฆ
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends โฆ
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimerโs and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emergingโฆ
